Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2005
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681804A Sulphonamide derivatives and their use as TACE inhibitors
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681793A Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680368A Process for production of substituted aniline compound
10/12/2005CN1680339A Benzimidazole derivative
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953800 Quinazoline derivatives
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/11/2005US6953787 5HT2C receptor modulators
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092881A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
10/06/2005WO2005092865A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092854A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005WO2005092849A1 Prolinyl derivatives for treating thrombosis
10/06/2005WO2005092066A2 Imidazole compounds
10/06/2005WO2005091752A2 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005WO2005091697A2 Thiourea compositions and uses thereof
10/06/2005WO2005020921A3 C-kit modulators and methods of use
10/06/2005US20050222427 Copper-catalysed ligation of azides and acetylenes
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222236 Viral polymerase inhibitors
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222181 Compounds in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
10/06/2005US20050222161 Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050221990 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/06/2005US20050221124 Fluorene-based compound and organic electroluminescent display device using the same
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005DE102004012901A1 Silylierte Carboxamide Silylated carboxamides
10/06/2005CA2561066A1 Antiviral 4-aminocarbonylamino-substituted imidazole compounds
10/06/2005CA2561057A1 Prolinyl derivatives for treating thrombosis
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560895A1 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/05/2005EP1581520A1 Compounds, compositions and methods
10/05/2005EP1581519A1 Ondansetron forms and processes of making the same
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581503A2 Ophthalmic compositions for treating ocular hypertension
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1581262A2 Contrast agent
10/05/2005EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005CN1678613A Hetereoaryl nitrile derivatives
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678587A CCK-1 receptor modulators
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678576A Pyrrolidine derivatives as oxytocin antagonists
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1676523A Method for preparing antihypertension losartan
10/05/2005CN1221545C Method for producing 4-(heteroaryl-methyl)-halogen-1 (2H)-2, 3-phthalazones
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/04/2005US6951951 Antitumor agents
10/04/2005US6951949 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
10/04/2005US6951881 (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
10/04/2005US6951874 Compounds
10/04/2005US6951864 4-imidazol-1-ylmethyl-pyrimidine derivatives
10/04/2005US6951861 Chemical compounds
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005090333A1 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090313A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides